Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-056354

Principal Accounting Officer sold 1,985 shares at $22.64 ($44,940)

  • Principal Accounting Officer acquired 3,964 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kihara James Principal Accounting Officer 2023-11-17 Option exercise +1,982 13,028 D: show line 1 in the form
Kihara James Principal Accounting Officer 2023-11-17 Option exercise +1,982 15,010 D: show line 2 in the form
Kihara James Principal Accounting Officer 2023-11-20 Sale −1,985 $22.64 $44,940 13,025 D: show line 3 in the form
Open-market sales · 1,985 sh · avg $22.64 · $44,940

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kihara James Principal Accounting Officer 2023-11-17 Option exercise · Restricted Stock Units −1,982 7,931 D: show line 4 in the form
Kihara James Principal Accounting Officer 2023-11-17 Option exercise · Restricted Stock Units −1,982 7,931 D: show line 5 in the form
Loading xslF345X05/doc4.xml…